Operating cash flow ranged from $1.1B in 2025Q4 to $13.9B in 2024Q3 and claims outflows rose to $90.7B in 2026Q3, indicating that cash conversion appears more tied to claims payment timing than to underlying earnings power, while dividends of roughly $2.0B per quarter remain steady.
UnitedHealth Group Incorporated (UNH) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 26.2B | 19.7B | 24.2B | 29.07B | 26.21B | 22.34B | 22.17B | 18.46B | 15.71B | 13.6B | 9.79B | 9.74B | 8.05B | 6.99B | 7.16B | 6.97B | 6.27B | 5.63B | 4.24B | 5.88B | 6.53B | 4.33B | 4.13B | 3B | 2.42B | 1.84B | 1.52B | 1.19B | 1.07B | 683M | 562.26M |
| Operating CF Growth % | 50.04% | -18.62% | -16.73% | 10.92% | 17.29% | 0.76% | 20.1% | 17.5% | 15.57% | 38.81% | 0.56% | 20.98% | 15.16% | -2.29% | 2.68% | 11.08% | 11.52% | 32.73% | -27.89% | -9.94% | 50.86% | 4.62% | 37.7% | 23.94% | 31.4% | 21.24% | 27.92% | 11.02% | 56.81% | 21.47% | 29.47% |
| Operating CF / Revenue % | 5.83% | 4.4% | 6.05% | 7.82% | 8.08% | 7.77% | 8.62% | 7.62% | 6.95% | 6.76% | 5.3% | 6.2% | 6.17% | 5.71% | 6.47% | 6.84% | 6.66% | 6.46% | 5.22% | 7.79% | 9.12% | 9.32% | 11.11% | 10.51% | 9.68% | 7.86% | 7.2% | 6.08% | 6.17% | 5.79% | 5.58% |
| Net Income | 15.88B | 12.81B | 15.24B | 22.38B | 20.12B | 17.29B | 15.77B | 13.84B | 11.99B | 10.56B | 7.02B | 5.81B | 5.62B | 5.63B | 5.53B | 5.14B | 4.63B | 3.82B | 2.98B | 4.65B | 4.16B | 3.3B | 2.59B | 1.82B | 1.35B | 913M | 736M | 568M | -166M | 460M | 355.64M |
| Depreciation & Amortization | 4.26B | 4.36B | 4.1B | 3.97B | 3.4B | 3.1B | 2.89B | 2.72B | 2.43B | 2.25B | 2.06B | 1.69B | 1.48B | 1.38B | 1.31B | 1.12B | 1.06B | 991M | 981M | 796M | 670M | 453M | 374M | 299M | 255M | 265M | 247M | 233M | 185M | 146M | 133.17M |
| Stock-Based Compensation | 1.02B | 971M | 1.02B | 1.06B | 925M | 800M | 679M | 697M | 638M | 597M | 485M | 406M | 364M | 331M | 421M | 401M | 326M | 334M | 305M | 505M | 404M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 380M | -989M | -296M | -245M | -673M | -814M | -60M | 230M | 42M | -748M | 81M | -308M | -415M | 1M | 5M | -8M | 248M | 7M | -166M | -127M | -267M | 167M | 125M | 91M | 154M | 40M | 73M | 35M | -184M | 91M | 0 |
| Other Non-Cash Items | 397M | 265M | 4.95B | 258M | 188M | 447M | 0 | 294M | 325M | 265M | -26M | 55M | 0 | -35M | 0 | 0 | 0 | 0 | -122M | 0 | 0 | 0 | 0 | 0 | -506M | -287M | -465M | -353M | -98M | 14M | 704K |
| Working Capital Changes | 3.47B | 2.28B | -808M | 1.64B | 2.25B | 1.52B | 2.9B | 683M | 294M | 679M | 183M | 2.08B | 1B | -306M | -106M | 309M | 1M | 471M | 263M | 49M | 1.56B | 406M | 1.05B | 788M | 1.17B | 913M | 930M | 706M | 1.33B | -28M | 72.75M |
| Cash from Investing | -11.43B | -8.69B | -20.53B | -15.57B | -28.48B | -10.37B | -12.53B | -12.7B | -12.38B | -8.6B | -9.36B | -18.39B | -2.53B | -3.09B | -8.65B | -4.17B | -5.34B | -976M | -5.07B | -4.15B | -2.1B | -3.49B | -1.64B | -745M | -1.39B | -1.14B | -968M | -623M | 21M | -1B | -472.51M |
| Capital Expenditures | -3.37B | -3.62B | -3.5B | -3.39B | -2.8B | -2.45B | -2.05B | -2.07B | -2.06B | -2.02B | -1.71B | -1.56B | -1.45B | -1.16B | -1.07B | -1.07B | -878M | -739M | -791M | -871M | -728M | -509M | -350M | -352M | -419M | -425M | -245M | -196M | -210M | -187M | -165.22M |
| Acquisitions | -1.61B | -4.51B | -13.41B | -10.14B | -21.46B | -4.82B | -7.14B | -8.34B | -6B | -2.13B | -1.76B | -16.16B | -1.92B | -317M | -6.28B | -1.41B | -2.3B | -486M | -3.81B | -262M | -670M | -2.92B | -2.23B | -590M | -302M | -92M | -76M | -334M | -464M | 0 | -51.86M |
| Purchase of Investments | 945M | 0 | -27.31B | -18.31B | -18.82B | -1.84B | -16.58B | -2.5B | -4.1B | -4.32B | -5.93B | -531M | -9.93B | -1.61B | -1.3B | -9.89B | -2.16B | -6.47B | -9.25B | -6.38B | -4.85B | -5.88B | -3.19B | -2.58B | -3.25B | -2.09B | -3.02B | -2.21B | -2.8B | -6.71B | -5.01B |
| Sale/Maturity of Investments | -6.73B | 361M | 27.83B | 16.54B | 11.99B | 15.3B | 13.74B | 15.63B | 9.91B | 10.27B | 11.62B | 9.41B | 799M | 10.56B | 8.6B | 8.2B | 5.7B | 249M | 8.6B | 3.37B | 4.1B | 5.82B | 4.12B | 2.78B | 2.58B | 1.47B | 2.36B | 2.06B | 3.44B | 5.89B | 4.75B |
| Other Investing | -667M | -915M | -4.14B | -275M | 2.62B | -16.55B | -506M | -15.41B | -10.14B | -10.39B | -11.58B | -9.55B | 9.96B | -10.56B | -8.6B | 0 | -5.7B | 6.47B | 185M | 0 | 52M | 0 | 0 | 0 | 0 | 0 | 12M | 51M | 59M | 0 | -1.5M |
| Cash from Financing | -16.06B | -11.64B | -3.51B | -11.53B | 4.23B | -7.46B | -3.59B | -5.63B | -4.37B | -3.44B | -1.01B | 12.24B | -5.29B | -4.95B | 471M | -2.49B | -1.61B | -2.27B | -605M | -3.19B | 474M | 593M | -762M | -1.13B | -1.44B | -585M | -739M | -605M | -198M | 34M | 6.86M |
| Dividends Paid | -8.17B | -7.92B | -7.53B | -6.76B | -5.99B | -5.28B | -4.58B | -3.93B | -3.32B | -2.77B | -2.26B | -1.79B | -1.36B | -1.06B | -820M | -651M | -449M | -36M | -37M | -40M | -41M | -19M | -18M | -9M | -9M | -9M | -5M | -6M | -34M | -35M | -34.09M |
| Share Repurchases | -9.77B | -5.54B | -9B | -8B | -7B | -5B | -4.25B | -5.5B | -4.5B | -1.5B | -1.28B | -1.2B | -4.01B | -3.17B | -3.08B | -2.99B | -2.52B | -1.8B | -2.68B | -6.6B | -2.35B | -2.56B | -3.45B | -1.61B | -1.81B | -1.13B | -1.18B | -983M | -436M | -16M | 0 |
| Stock Issued | -444M | 0 | 1.85B | 1.35B | 1.25B | 1.35B | 1.44B | 1.04B | 838M | 688M | 429M | 402M | 462M | 598M | 1.08B | 381M | 272M | 282M | 299M | 712M | 397M | 423M | 583M | 268M | 205M | 178M | 228M | 102M | 84M | 79M | 41.56M |
| Debt Issuance (Net) | -2M | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | -620K |
| Other Financing | 8.14B | 1.09B | -3.48B | -2.4B | 3.43B | 344M | 2.66B | -187M | -679M | 3.45B | 1.54B | 618M | -314M | -872M | -1.27B | 428M | 989M | 729M | 682M | -827M | 1.89B | 90M | 75M | 4M | 0 | 0 | 0 | 0 | 0 | 6M | 0 |
| Net Change in Cash | 2.39B | 2.81B | -115M | 2.06B | 1.99B | 4.45B | 5.94B | 119M | -1.11B | 1.55B | -493M | 3.43B | 219M | -1.13B | -1.02B | 306M | -677M | 2.37B | -1.44B | -1.46B | 4.9B | 1.43B | 1.73B | 1.13B | -410M | 121M | -186M | -39M | 894M | -287M | 96.61M |
| Exchange Rate Effect | 3.69B | 3.44B | -280M | 97M | 34M | -62M | -116M | -20M | -78M | -5M | 78M | -156M | -5M | -86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 28.59B | 25.31B | 25.43B | 23.36B | 21.38B | 16.92B | 10.98B | 10.87B | 11.98B | 10.43B | 10.92B | 7.5B | 7.28B | 8.41B | 9.43B | 9.12B | 9.8B | 7.43B | 8.87B | 10.32B | 5.42B | 3.99B | 2.26B | 1.13B | 1.54B | 1.42B | 1.6B | 1.64B | 750M | 1.04B | 940.11M |
| Cash at End | 25.84B | 28.12B | 25.31B | 25.43B | 23.36B | 21.38B | 16.92B | 10.98B | 10.87B | 11.98B | 10.43B | 10.92B | 7.5B | 7.28B | 8.41B | 9.43B | 9.12B | 9.8B | 7.43B | 8.87B | 10.32B | 5.42B | 3.99B | 2.26B | 1.13B | 1.54B | 1.42B | 1.6B | 1.64B | 750M | 1.04B |
| Free Cash Flow | 22.83B | 16.07B | 20.7B | 25.68B | 23.4B | 19.89B | 20.12B | 16.39B | 13.65B | 11.57B | 8.09B | 8.18B | 6.6B | 5.83B | 6.08B | 5.95B | 5.39B | 4.89B | 3.45B | 5.01B | 5.8B | 3.82B | 3.79B | 2.65B | 2B | 1.42B | 1.28B | 993M | 861M | 496M | 397.04M |
| FCF Growth % | 31.4% | -22.36% | -19.38% | 9.73% | 17.67% | -1.16% | 22.76% | 20.09% | 17.95% | 43.05% | -1.15% | 23.92% | 13.28% | -4.19% | 2.27% | 10.29% | 10.42% | 41.75% | -31.14% | -13.66% | 51.9% | 0.85% | 42.78% | 32.29% | 41.23% | 11.21% | 28.5% | 15.33% | 73.59% | 24.93% | 22.15% |
| FCF Margin % | 5.08% | 3.59% | 5.17% | 6.91% | 7.22% | 6.92% | 7.83% | 6.77% | 6.03% | 5.75% | 4.38% | 5.21% | 5.06% | 4.76% | 5.5% | 5.84% | 5.73% | 5.61% | 4.25% | 6.64% | 8.1% | 8.22% | 10.17% | 9.28% | 8.01% | 6.05% | 6.04% | 5.08% | 4.96% | 4.21% | 3.94% |
| FCF per Share | 25.31 | 17.66 | 22.29 | 27.38 | 24.64 | 20.8 | 20.94 | 16.97 | 13.89 | 11.75 | 8.36 | 8.46 | 6.7 | 5.7 | 5.82 | 5.47 | 4.77 | 4.14 | 2.78 | 3.68 | 4.14 | 2.86 | 2.88 | 2.15 | 1.58 | 1.09 | 0.95 | 0.7 | 0.56 | 0.32 | 0.27 |
Quick answers to the most common questions about buying UNH stock.
UnitedHealth Group Incorporated (UNH) generated $19.70B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
UnitedHealth Group Incorporated (UNH) generated $16.07B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
UnitedHealth Group Incorporated (UNH) spent $3.62B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, UnitedHealth Group Incorporated (UNH) returned $7.92B to shareholders via cash dividends and spent $5.54B on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Medicare Advantage utilization and DOJ scrutiny
Metrics are mathematically derived from official filings.
Claims Outflows Dominate Quarterly Cash Profile
According to reported quarterly figures, UNH's claims and loss payments rose from $75.4B in 2026Q2 to $90.7B in 2026Q3, and this step-up in cash outflow appears to be consuming most of the premium inflow base during the period.
The quarterly claims outflow series is large relative to net income, which suggests cash generation is highly sensitive to the timing of medical payments versus premium receipts. The spike in 2026Q3 aligns with the utilization pressures noted in the prior income statement review and may indicate that Medicare Advantage cost trends are outpacing pricing. Investors should monitor whether this payment cadence reflects seasonal or structural utilization shifts, as sustained elevation would weigh on float-driven cash generation.
Operating Cash Flow Swings Track Reserve Timing
Based on UNH's reported figures, operating cash flow ranged from $1.1B in 2025Q4 to $13.9B in 2024Q3, a volatility pattern that appears more closely tied to claims payment timing than to underlying earnings power.
The OCF to net income ratio moved from 0.43 to 2.30 across the ten-quarter window, and in 2025Q4 the ratio of 110.80 reflects a near-zero net income base rather than meaningful cash generation. This pattern suggests that quarterly operating cash flow is being driven by reserve build and release dynamics rather than steady premium-to-claims conversion. Trailing cash generation may therefore be a more reliable gauge than any single quarter.
Investment Portfolio Rebalancing Drives Liquidity
As reported in the cash flow statements, UNH shifted from net purchases of $14.1B in 2025Q3 to net sales of $14.1B in 2025Q4, indicating active rotation of the investment float rather than a static holding pattern.
Large swings between purchases and sales of investments suggest management is actively managing portfolio duration and liquidity against claims obligations. The 2025Q4 sale activity coincides with weak net income, which may indicate that portfolio liquidation was used to fund claims payments or capital returns. Investors should note that the realized yield and the pace of reinvestment are not disclosed here, limiting assessment of the income effect of these moves.
Dividend Coverage Stable but Buybacks Irregular
Based on reported cash flows, UNH paid steady dividends of roughly $1.9B to $2.1B per quarter across the window, while buybacks varied from zero to $5.0B, making repurchase activity the less predictable component of capital return.
Dividend outflows remained consistent even as quarterly net income fell near zero in 2025Q4, which suggests the payout is supported by cash flow rather than current earnings. Buybacks, by contrast, appear to flex with cash availability, and the $5.0B repurchase in 2024Q4 exceeded quarterly OCF in several periods. This implies that repurchases may be partly funded from portfolio liquidation, warranting monitoring of whether capital return remains self-funded over time.
Reported Cash Strength May Mask Reserve Risk
As reported in the quarterly cash flow data, UNH's trailing operating cash generation looks adequate, but the DOJ Medicare Advantage investigation and elevated utilization could weaken future float conversion in ways a beat-and-raise quarter does not resolve.
Quarterly operating cash flow can be lifted by reserve timing and claims payment lags, so a strong quarter such as 2024Q3 may overstate the sustainable conversion of premiums into cash. Based on the supplied data, unresolved regulatory exposure and potential overpayment recoveries are not quantified, and they may reduce future operating cash if penalties or repayments materialize. Investors should monitor whether operating cash flow holds up once claims normalize, rather than relying on the reported quarterly peaks.